Stock listing

Munich:3MM Advicenne SA Aktie

German listing (Munich) of Advicenne SA · home listing Euronext:ALDVI

Follow Advicenne SA into a list and get an email when it puts out news.

Home listing price · EURONEXT:ALDVI

€0.65 EUR 0.00 (0.0%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, EURONEXT:ALDVI

Since Jul 6, 2026 -70.6% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
€0.65 – €0.69 EUROct 16, 2026
Volume
17,871 sharesOct 16, 2026
Market value
€9.90M EURAt the close on Oct 16, 2026 · price × 15.24M shares outstanding
Advicenne SA logo
Ticker
Munich:3MM
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
Munich
Currency
EUR

What changed lately

Latest news

Advicenne Extends Its Cash Runway to 2028 Through Bond Financing and Strong Operational Performance

Oct 12, 2026

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

Oct 1, 2026

Advicenne Reports First Half Financial Results as of June 30, 2026, and Updates on Its Activities

Sep 17, 2026

Advicenne decides to withdraw its ADV7103 New Drug Application in the USA

Aug 31, 2026

Advicenne Announces the Reimbursement of Sibnayal® for the Treatment of dRTA in Spain

Jul 20, 2026

Advicenne: Net Revenue for the First Half of 2026 Driven by Reimbursement of Sibnayal® and Likozam® in France

Jul 16, 2026

Advicenne Announces the Unlimited Renewal of the Marketing Authorization for Sibnayal® in the United Kingdom

Jul 1, 2026

Advicenne secures its cash runway to Q2 2027 through a bond financing of a nominal amount of up to EUR3.8 million

Jun 23, 2026

Advicenne Secures Its Cash Runway to Q2 2027 through a Bond Financing of a Nominal Amount of up to €3.8 Million

Jun 22, 2026

Advicenne Granted Reimbursement for Likozam® in France and Sees Thereby Its Debt Reduced by Nearly €6 Million

Jun 1, 2026

All Advicenne SA news

Financings

  • Convertible bonds

    Oct 12, 2026 · US$1.12M

    Closed: €1M raised

    Buyers: fund managed by L1 Capital (remaining tranche of bond financing, net €1.0 million)

    Use of proceeds: Strengthen cash position and extend financial runway to 2028

    Closed Oct 12, 2026

Read by 6ix AI from the company's releases

Decks

Advicenne SA on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
22 in the last 12 months · 28 in all · newest Oct 12, 2026 · oldest 2025
Decks
6 decks · latest June 2025

Where Advicenne SA is listed

ListingExchangeCountryCurrency
Euronext:ALDVI · Home listingEuronextFranceEUR
gettex:3MMgettexGermanyEUR
LS Exchange:A2H8SULS ExchangeGermanyEUR
Lang & Schwarz:A2H8SULang & SchwarzGermanyEUR
Frankfurt:3MMFrankfurtGermanyEUR
Dusseldorf:3MMDusseldorfGermanyEUR
Munich:3MM · This pageMunichGermanyEUR
OTC:ADVVFOTCUnited StatesUSD
Stuttgart:3MMStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Advicenne SA.